Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 7Carcinoma, Renal Cell 7Carcinoma, Hepatocellular 6Uterine Cervical Neoplasms 2Melanoma 2Endometrial Neoplasms 2von Hippel-Lindau Disease 1Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Penile Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Hematologic Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1Breast Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1Advanced Malignancies 1Advanced Gastric or Gastroesophageal Junction Adenocarcinoma 1Adenocarcinoma 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Epirubicin 2pembrolizumab 1lenvatinib 1anlotinib 1amivantamab 1Pemetrexed 1Observation 1Nivolumab 1Ipilimumab 1Glutamate Carboxypeptidase II 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Adenoid Cystic × lenvatinib × 30 days × Clear all
NCT02780310 2026-06-03

Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
33 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡